Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo

1 Department of Medicine and 2 School of Biological Sciences, University of Auckland, Auckland, New Zealand Submitted 20 December 2005 ; accepted in final form 7 August 2006 Several hormones that regulate nutritional status also impact on bone metabolism. Preptin is a recently isolated 34-amino acid...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology: endocrinology and metabolism 2007-01, Vol.292 (1), p.E117-E122
Hauptverfasser: Cornish, J, Callon, K. E, Bava, U, Watson, M, Xu, X, Lin, J. M, Chan, V. A, Grey, A. B, Naot, D, Buchanan, C. M, Cooper, G. J. S, Reid, I. R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1 Department of Medicine and 2 School of Biological Sciences, University of Auckland, Auckland, New Zealand Submitted 20 December 2005 ; accepted in final form 7 August 2006 Several hormones that regulate nutritional status also impact on bone metabolism. Preptin is a recently isolated 34-amino acid peptide hormone that is cosecreted with insulin and amylin from the pancreatic -cells. Preptin corresponds to Asp 69 -Leu 102 of pro-IGF-II. Increased circulating levels of a pro-IGF-II peptide complexed with IGF-binding protein-2 have been implicated in the high bone mass phenotype observed in patients with chronic hepatitis C infection. We have assessed preptin's activities on bone. Preptin dose-dependently stimulated the proliferation (cell number and DNA synthesis) of primary fetal rat osteoblasts and osteoblast-like cell lines at periphysiological concentrations (>10 –11 M). In addition, thymidine incorporation was stimulated in murine neonatal calvarial organ culture, likely reflecting the proliferation of cells from the osteoblast lineage. Preptin did not affect bone resorption in this model. Preptin induced phosphorylation of p42/p44 MAP kinases in osteoblastic cells in a dose-dependent manner (10 –8 -10 –10 M), and its proliferative effects on primary osteoblasts were blocked by MAP kinase kinase inhibitors. Preptin also reduced osteoblast apoptosis induced by serum deprivation, reducing the number of apoptotic cells by >20%. In vivo administration of preptin increased bone area and mineralizing surface in adult mice. These data demonstrate that preptin, which is cosecreted from the pancreatic -cell with amylin and insulin, is anabolic to bone and may contribute to the preservation of bone mass observed in hyperinsulinemic states such as obesity. osteoblast; bone-active hormone; bone anabolic Address for reprint requests and other correspondence: J. Cornish, Dept. of Medicine, Univ. of Auckland, Private Bag 92019, Auckland, NZ (e-mail: j.cornish{at}auckland.ac.nz )
ISSN:0193-1849
1522-1555
DOI:10.1152/ajpendo.00642.2005